Skip to Navigation
London School of Hygiene & Tropical Medicine Malaria Centre

Malaria research in social and economic studies

Independent Evaluation of the Affordable Medicines Facility – Malaria (AMFm).

LSHTM investigators:
Kara Hanson, Catherine Goodman, Sarah Tougher, Barbara Willey, Andrea Mann & Becky Thomson.
External collaborators:
ICF International; Population Services International; Centre de Recherche pour le Développement Humain, Senegal; Centre International d’Études et de Recherches sur les Populations Africaines, Niger; Komfo Anokye Teaching Hospital, Ghana; Drugs for Neglected Diseases Initiative; Ifakara Health Institute, Tanzania.
Funding body:
The Global Fund to Fight AIDS, Tuberculosis and Malaria

The aim of the independent evaluation of Phase 1 of the Affordable Medicines Facility – malaria (AMFm) is to assess whether, and to what extent, the first phase of AMFm achieves its objectives, which are:  (i) to increase ACT affordability, (ii) to increase ACT availability, (iii) to increase ACT use, including among vulnerable groups, and (iv) to “crowd out” other oral antimalarials by gaining market share.

The evaluation results will be summarized in a report to be considered by the Global Fund Board at the end of Phase 1, in November 2012.

The evaluation is being carried out in all 8 operational Phase 1 pilots (Ghana, Kenya, Madagascar, Niger, Nigeria, Tanzania mainland, Uganda, and Zanzibar).  It is based on a non-experimental design with a pre- and post-test intervention assessment in which each participating country is treated independently as a case study. In each  country, a nationally representative survey of outlets stocking antimalarial medicines was conducted at baseline and endline.  In addition to measuring the changes in key indicators pre- and post-intervention, the evaluation includes an assessment of the implementation process and a comprehensive documentation of the context both to inform assessments about causality and to aid in generalizability to other contexts.  Analysis of secondary household survey data is used to assess the effects of the programme on ACT use.